FdaApplication
ANDA 215026
Identifiers
- fda_app_no: ANDA215026
Properties
| Property | Value |
|---|---|
| applicant_name | CIPLA LTD |
| application_type | ANDA |
| approval_date | 2022-02-23 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DEFERASIROX | DEFERASIROX | 180MG | GRANULE;ORAL |
| DEFERASIROX | DEFERASIROX | 360MG | GRANULE;ORAL |
| DEFERASIROX | DEFERASIROX | 90MG | GRANULE;ORAL |
3 products